The concept of dietary microdosing is potentially important because it points out two areas that deserve investigation but which have been neglected by the academic scientific community: First, I suggest that the potential psychological and psychiatric impact of dietary ingredients may be larger than previously appreciated, particularly when they are combined in specific ways. Many spices and medicinal plants have been studied individually in antidepressant assays and clinical studies but not, to my knowledge, as synergistic combinations.
Apart from studying curcumin as an add-on therapy [e. Second, it appears to be likely that dietary ingredients can modulate the affect the peak, duration, or quality of the experience produced by psychoactive drugs [including, but not limited to, cannabis and psychedelic drugs 41 ].
I suggest that this topic is worth studying within the realm of psychiatric neuroscience rather than remaining in the purview of self-experimentation by enthusiasts 25 , The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Polito V, Stevenson RJ. A systematic study of microdosing psychedelics. PLoS One 14 2 :e The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.
Psychopharmacology Berl 4 — Taking the spice route: psychoactive properties of culinary spices. Curr Psychiatry 13 4 — Google Scholar. Gertsch J. Cannabimimetic phytochemicals in the diet—an evolutionary link to food selection and metabolic stress adaptation?
Br J Pharmacol 11 — Russo EB. Beyond cannabis: plants and the endocannabinoid system. Trends Pharmacol Sci 37 7 — Cannabimimetic plants: are they new cannabinoidergic modulators? Planta 6 Anandamide and the vanilloid receptor TRPV1. Vitam Horm — Vanilloid and TRP channels: a family of lipid-gated cation channels.
Neuropharmacology 42 7 — Brain cannabinoids in chocolate. Nature —8. Trick or treat from food endocannabinoids? Nature —7. Indirect modulation of the endocannabinoid system by specific fractions of nutmeg total extract. Pharm Biol 54 12 —8. Hassanzadeh P, Hassanzadeh A. Neurochem Res 37 5 — Beta-caryophyllene is a dietary cannabinoid. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Br J Pharmacol — Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology — Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol 1 —8. Neuropharmacology — Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex.
Effects of psychedelics There is no safe level of drug use. Psychedelics affect everyone differently, based on: size, weight and health whether the person is used to taking it whether other drugs are taken around the same time the amount taken the strength of the drug varies from batch to batch.
Using psychedelics with other drugs The effects of mixing psychedelics with other drugs, including alcohol, prescription medications and over-the-counter medicines, are often unpredictable.
Health and safety There is no safe way to use psychedelic drugs. It is difficult to predict the strength and effects of psychedelics even if they have been taken before , as the strength and potency can vary from batch to batch. People with mental health conditions or a family history of these conditions should avoid using psychedelics. Taking psychedelics in a familiar environment in the company of people who are known and trusted may alleviate any unpleasant emotional effects.
Anxiety can be counteracted by taking deep, regular breaths while sitting down. Dependence and tolerance Most psychedelics produce tolerance rapidly and psychological dependence can occur in some people. Path2Help Not sure what you are looking for?
Find out more. Psychonaut Wiki. Psychedelics Psychonaut Wiki. DOM Dance Safe. Peyote Barratt, M. Drug science. Campbell, A. The Australian illicit drug guide.
Melbourne: Black Inc. LSD basic information. Object perception as Bayesian inference. Bayesian models of object perception. Kitcher, P. Explanatory unification. Kitcher and W. Klee, G. Lysergic acid diethylamide LSD and ego functions. Psychiatry 8, — Mescal visions and eidetic vision. Knauer, A. A preliminary note on the psychic action of mescalin, with special reference to the mechanism of visual hallucinations.
Knill, D. The Bayesian brain: the role of uncertainty in neural coding and computation. Trends Neurosci. Kometer, M. Psychiatry 69, — Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Psychiatry 72, — Serotonergic hallucinogen-induced visual perceptual alterations. Kraehenmann, R. LSD increases primary process thinking via serotonin 2A receptor activation.
Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation. Kraepelin, E. Jena: G. Krebs, T. Psychedelics and mental health: a population study. PLoS One 8:e Kuypers, K. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Kwisthout, J. Brain Cogn. Free energy minimization and information gain: the devil is in the details.
Leary, T. Reactions to psilocybin administered in a supportive environment. Lebedev, A. Lee, T. Hierarchical Bayesian inference in the visual cortex. A Opt. Image Sci. Letheby, C. Self unbound: ego dissolution in psychedelic experience. Lewin, L. On Anhalonium lewinii and other cacti. CrossRef Full Text. Phantastica, Narcotic and Stimulating Drugs. Lieberman, J. Back to the future: research renewed on the clinical utility of psychedelic drugs.
Liechti, M. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Limanowski, J. Minimal self-models and the free energy principle. Luke, D. The induction of synaesthesia with chemical agents: a systematic review. MacKay, D. Number 34 , eds W. Ashby, C. Shannon, and J. MacLean, K. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
Maclean, K. Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin. Study Relig.
Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Marshall, P. Martindale, C. The effects of psilocybin on primary process content in language. PubMed Abstract Google Scholar. Masters, R. The Varieties of Psychedelic Experience. McKenna, D. New world tryptamine hallucinogens and the neuroscience of ayahuasca.
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29, — Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. Merkur, D. Merriam-Webster Springfield, MA: Merriam-Webster.
Metzinger, T. Looking for the self: phenomenology, neurophysiology and philosophical significance of drug-induced ego dissolution. Mitchell, S. Remarks on the effects of Anhelonium Lewinii the Mescal Button. Montague, P. Computational psychiatry. Moreau, J. Paris: Fortin. Moreno, F. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Psychiatry 67, — Morrison, M. Cambridge: Cambridge University Press. Mumford, D. On the computational architecture of the neocortex.
Muthukumaraswamy, S. Broadband cortical desynchronization underlies the human psychedelic state. Myers, F. Human Personality and its Survival of Bodily Death. Natale, M. Effect of psychotomimetics LSD and dextroamphetamine on the use of primary- and secondary-process language. Effect of psychototmimetics LSD and dextroamphetamine on the use of figurative language during psychoanalysis. Neisser, U. Cognitive Psychology. Nichols, D. Nour, M. Oizumi, M.
From the phenomenology to the mechanisms of consciousness: integrated information theory 3. PLoS Comput. Osborne, H. Osmond, H. A review of the clinical effects of psychotomimetic agents. Schizophrenia: a new approach. Ott, U. Pahnke, W. The experimental use of psychedelic LSD psychotherapy.
Palhano-Fontes, F. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.
PLoS One e Pink-Hashkes, S. Pokorny, T. Effect of psilocybin on empathy and moral decision-making. Preller, K. The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Phenomenology, structure, and dynamic of psychedelic states.
Prentiss, D. Anhalonium lewinie Mescal buttons. Purpura, D. DeBold and R. Rao, R. Predictive coding in the visual cortex: a functional interpretation of some extra-classical receptive-field effects. Rapaport, D. On the psycho-analytic theory of thinking. Psycho Anal. Ray, T. Psychedelics and the human receptorome.
PLoS One 5:e Hypotheses 87, 48— Riba, J. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology 50, 89— Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
Psychometric assessment of the Hallucinogen Rating Scale. Drug Alcohol Depend. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology , 85— Rickli, A. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Roseman, L. The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression.
LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Ross, S. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Rouhier, A. Le Peyotl. Paris: G. Russ, S. Antecedents of mystical experience and dread in intensive meditation. Sandison, R. Psychological aspects of the LSD treatment of the neuroses. Further studies in the therapeutic value of lysergic acid diethylamide in mental illness.
Sanz, C. The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports. Savage, C.
Variations in ego feeling induced by D-lysergic acid diethylamide LSD Schartner, M. Schenberg, E. Acute biphasic effects of ayahuasca. Schmid, Y. Acute effects of lysergic acid diethylamide in healthy subjects. Psychiatry 78, — Schmied, L. Schultes, R. The Botany and Chemistry of Hallucinogens. Springfield, IL: Charles C. Sessa, B. Is it time to revisit the role of psychedelic drugs in enhancing human creativity? Seth, A. Explanatory correlates of consciousness: theoretical and computational challenges.
Shanon, B. Shaw, E. Some serotoninlike activities of lysergic acid diethylamide. Shimamura, A. Toward a cognitive neuroscience of metacognition. Shulgin, A. Pihkal: A Chemical Love Story. Berkeley, CA: Transform Press. Tihkal: the Continuation. Siegel, R. Siegel and L. Sinke, C. Genuine and drug-induced synesthesia: a comparison. Smythies, J. Analysis of Perception. London: Routledge and Paul. Speth, J. Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide.
Spitzer, M. Increased activation of indirect semantic associations under psilocybin. Psychiatry 39, — Stace, W. Mysticism and Philosophy. Stockings, G. A clinical study of the mescaline psychosis, with special reference to the mechanism of the genesis of schizophenic and other psychotic states. Sci 86, 29— Strassman, R. Adverse reactions to psychedelic drugs.
A review of the literature. Dose-response study of N,N-dimethyltryptamine in humans. Subjective effects and preliminary results of a new rating scale. Psychiatry 51, 98— Studerus, E. Prediction of psilocybin response in healthy volunteers.
PLoS One 7:e Psychometric evaluation of the altered states of consciousness rating scale OAV. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. Suler, J. Primary process thinking and creativity. Swanson, L. The predictive processing paradigm has roots in kant. Sweat, N. The associations of naturalistic classic psychedelic use, mystical experience, and creative problem solving.
Psychoactive Drugs 48, — Tagliazucchi, E. Enhanced repertoire of brain dynamical states during the psychedelic experience. Increased global functional connectivity correlates with LSD-induced Ego dissolution. Tenenbaum, J. How to grow a mind: statistics, structure, and abstraction. Terhune, D. A placebo-controlled investigation of synaesthesia-like experiences under LSD.
Neuropsychologia 88, 28— Tononi, G. An information integration theory of consciousness. BMC Neurosci. Consciousness as integrated information: a provisional manifesto. Consciousness and complexity. The neural correlates of consciousness: an update. Tupper, K. Psychedelic medicine: a re-emerging therapeutic paradigm.
CMAJ , — Turton, S. A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. Drug Abuse Rev. Valle, M. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. Viol, A. Vollenweider, F. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.
Neuropsychopharmacology 32, — Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
Neuroreport 9, — Wackermann, J. Effects of varied doses of psilocybin on time interval reproduction in human subjects.
Waldman, A. Ward, J. Watts, R. Wiese, W. Metzinger and W. Winkelman, M. The mechanisms of psychedelic visionary experiences: hypotheses from evolutionary psychology. Wittmann, M. Effects of psilocybin on time perception and temporal control of behaviour in humans.
Wong, S. Leading the high life. Woolley, D. A biochemical and pharmacological suggestion about certain mental disorders. Zizo Keywords : psychedelic drugs, LSD, psilocybin, ego dissolution, cognitive flexibility, entropic brain theory, integrated information theory, predictive processing.
0コメント